Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Bioxyne Limited ( (AU:BXN) ) has issued an update.
Bioxyne Limited has issued a total of 5,600,000 shares, with 4,400,000 shares allocated to directors as part of a capital raise and 1,200,000 shares to consultants in lieu of cash payments. This move, approved by shareholders, reflects the company’s strategic financial management and compliance with relevant sections of the Corporations Act, indicating a stable regulatory standing.
The most recent analyst rating on (AU:BXN) stock is a Buy with a A$0.04 price target. To see the full list of analyst forecasts on Bioxyne Limited stock, see the AU:BXN Stock Forecast page.
More about Bioxyne Limited
Average Trading Volume: 2,764,348
Technical Sentiment Signal: Buy
Current Market Cap: A$85.4M
For detailed information about BXN stock, go to TipRanks’ Stock Analysis page.